Delivery Order SPE2DX22D0039-SPE2D826F0DP0
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,293.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 6, 2026. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,374.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (Doing Business As AmerSourceBergen). This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion on January 7, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,820.16 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with completion expected by January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,203.89 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. The contract, awarded on January 6, 2026, utilizes a firm fixed-price structure with an ultimate completion date of January 7, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,944.44 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with performance completion scheduled for January 7, 2026. This firm fixed-price delivery order was issued without set-aside designation, reflecting competitive award practices. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,122.80 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which was not set aside for any specific business category, represents a child contract under the company's parent organization Cencora, Inc. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,751.07 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The contractor's place of performance is Conshohocken, Pennsylvania, where the company maintains its corporate office. AmerSourceBergen Drug Corp operates as a...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $62,347.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price contract, with an ultimate completion date of January 7, 2026, was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,869.95 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract represents a child award under the parent entity Cencora, Inc., which operates under the AmerSourceBergen...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $179,323.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 7, 2026, carries no set-aside designation and was competitively awarded. The work will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- SPE2DX22D0039Indefinite Delivery Contract
- SPE2DX22D0039-SPE2D826F0DP0Delivery Order
On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,276.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. AmerSourceBergen Drug Corp is a critical vendor in the federal pharmaceutical supply chain, supplying a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems and other government agencies. As a subsidiary of Cencora, Inc., the company operates under a significant IDC valued at up to $999,999,999.00 through December 2026 that enables it to deliver diverse pharmaceutical products globally. This particular delivery order exemplifies the company's role in fulfilling ongoing medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contract vehicles designed to ensure reliable access to essential medications and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 1/5/26 |